Photo-Optical Methods Can Lead to Clinically Relevant Overestimation of Fibrinogen Concentration in Plasma Diluted With Hydroxyethyl Starch

被引:20
作者
Adam, Susanne [1 ]
Karger, Ralf [1 ]
Kretschmer, Volker [1 ]
机构
[1] Univ Hosp Marburg, Inst Transfus Med & Hemostaseol, Marburg, Germany
关键词
fibrinogen concentration; fibrinogen measurement; hydroxyethyl starch; major blood loss; massive transfusion; volume replacement; IN-VITRO; CLOT FORMATION; COAGULATION; COAGULOPATHY; HEMODILUTION; ASSAYS; SUBSTITUTES; TRANSFUSION; HEMOSTASIS; GUIDELINES;
D O I
10.1177/1076029609342090
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Adequate fibrinogen concentration is a crucial component of sufficient perioperative/posttraumatic hemostasis. In major blood loss, large volumes of fluids are being administered, which have been shown to interfere with valid determination of fibrinogen concentration. This may lead to wrong treatment decisions. We studied the variables that cause the discrepancies between measured and true fibrinogen concentrations in samples diluted with volume replacement fluids. Methods: Citrated plasma samples of healthy volunteers were diluted by 30% and 50% with phosphate buffered saline (PBS), hydroxyethyl starch (HES) 10% (200/0.5), or gelatine (GEL). Fibrinogen concentrations of diluted samples were derived from the prothrombin time (PT) and the Clauss method (CLS) was applied. With the latter, several modifications and combinations of detection principles and thrombin reagents were investigated. Values were compared with "true," that is, calculated values based on the results of undiluted samples for each method. Results: Photo-optical methods resulted in significant overestimation of the fibrinogen concentration in blood diluted with HES, depending on the thrombin reagent used. This was particularly true for modifications of the CLS aimed at measuring low fibrinogen concentrations. Use of another thrombin reagent gave satisfactory results for this modification. The validity of mechanical end point determination methods was considered sufficient and was not influenced by the use of different thrombin reagents. Conclusions: Fibrinogen determination methods used in situations of major blood loss need to be validated with samples containing significant amounts of volume replacement fluids, particularly colloids. Only some combinations of test principle, detection method, and reagents will give valid results.
引用
收藏
页码:461 / 471
页数:11
相关论文
共 22 条
[1]  
Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1177/096228029900800204
[2]   Effects of different plasma substitutes on blood coagulation: A comparative review [J].
de Jonge, E ;
Levi, M .
CRITICAL CARE MEDICINE, 2001, 29 (06) :1261-1267
[3]   Fibrinogen concentrate reverses dilutional coagulopathy induced in vitro by saline but not by hydroxyethyl starch 6% [J].
De Lorenzo, C ;
Calatzis, A ;
Welsch, U ;
Heindl, B .
ANESTHESIA AND ANALGESIA, 2006, 102 (04) :1194-1200
[4]   Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes:: improvements of the induced coagulopathy with fibrinogen concentrate [J].
Fenger-Eriksen, C ;
Anker-Moller, E ;
Heslop, J ;
Ingerslev, J ;
Sorensen, B .
BRITISH JOURNAL OF ANAESTHESIA, 2005, 94 (03) :324-329
[5]   The effect of the combined administration of colloids and lactated Ringer's solution on the coagulation system:: An in vitro study using Thrombelastograph® coagulation analysis (ROTEG®) [J].
Fries, D ;
Innerhofer, P ;
Klingler, A ;
Berresheim, U ;
Mittermayr, M ;
Calatzis, A ;
Schobersberger, W .
ANESTHESIA AND ANALGESIA, 2002, 94 (05) :1280-1287
[6]   RETRACTED: Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients (Retracted article. See vol. 25, pg. 755, 2011) [J].
Haisch, G ;
Boldt, J ;
Krebs, C ;
Suttner, S ;
Lehmann, A ;
Isgro, F .
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2001, 15 (03) :316-321
[7]   RETRACTED: The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery (Retracted Article) [J].
Haisch, G ;
Boldt, J ;
Krebs, C ;
Kumle, B ;
Suttner, S ;
Schulz, A .
ANESTHESIA AND ANALGESIA, 2001, 92 (03) :565-571
[8]   Massive transfusion and coagulopathy: pathophysiology and implications for clinical management [J].
Hardy, Jean-Francois ;
de Moerloose, Philippe ;
Samama, Charles Marc .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 2006, 53 (06) :S40-S58
[9]   High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion [J].
Heindl, B ;
DeLorenzo, C ;
Spannagl, M .
ANAESTHESIST, 2005, 54 (08) :787-790
[10]  
Hiippala ST, 1995, BLOOD COAGUL FIBRIN, V6, P743